![Eva Arlander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eva Arlander
Direttore operativo presso LIPIGON PHARMACEUTICALS AB
Patrimonio netto: - $ in data 31/05/2024
Profilo
Eva Arlander is currently the Chief Executive Officer at SciGazer AB, as well as the Chief Development Officer at InDex Pharmaceuticals Holding AB and the Chief Operating Officer at Lipigon Pharmaceuticals AB.
Previously, she held positions as Vice President-Marketing at Medivir AB, Vice President-Clinical Research & Development at Affibody Medical AB, and Head-Department at The Medical Products Agency.
Arlander earned a doctorate degree from Karolinska Institutet and a graduate degree from the University of Uppsala.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
FLERIE AB
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Eva Arlander
Società | Posizione | Inizio |
---|---|---|
FLERIE INVEST AB | Corporate Officer/Principal | 02/05/2022 |
LIPIGON PHARMACEUTICALS AB | Direttore operativo | 01/01/2021 |
SciGazer AB | Amministratore Delegato | - |
Precedenti posizioni note di Eva Arlander
Società | Posizione | Fine |
---|---|---|
MEDIVIR AB | Vendite & Marketing | - |
The Medical Products Agency
![]() The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Corporate Officer/Principal | - |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Eva Arlander
Karolinska Institutet | Doctorate Degree |
University of Uppsala | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MEDIVIR AB | Health Technology |
FLERIE INVEST AB | Health Technology |
LIPIGON PHARMACEUTICALS AB | Health Technology |
Aziende private | 3 |
---|---|
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
The Medical Products Agency
![]() The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Health Technology |
SciGazer AB |
- Borsa valori
- Insiders
- Eva Arlander